中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
26期
24-25,26
,共3页
CT引导%射频消融术%肝癌%临床
CT引導%射頻消融術%肝癌%臨床
CT인도%사빈소융술%간암%림상
CT-guided%Radiofrequency ablation%Liver cancer%Clinical
目的:探究并评价CT引导下射频消融术(RFA)治疗肝癌的临床效果。方法:选取2012年4月-2013年4月在本院行CT引导下射频消融术治疗肝癌的60例患者,探究分析CT引导下射频消融术对所有患者的临床疗效及预后情况。结果:所有患者在手术中的血压、脉搏及血氧饱和度与术前相比均无明显变化(P>0.05),而治疗后平均AFP和CEA检测值均明显低于治疗前,差异均有统计学意义(P<0.05)。60例患者肿瘤完全坏死56例,占93.3%;不完全坏死3例,占5.0%;部分坏死1例,占1.7%。60例患者在1年内复发16例,占26.7%;1年内死亡患者1例,存活59例,1年生存率为98.3%。结论:CT引导下射频消融术(RFA)治疗肝癌的临床效果良好,值得在临床上推广。
目的:探究併評價CT引導下射頻消融術(RFA)治療肝癌的臨床效果。方法:選取2012年4月-2013年4月在本院行CT引導下射頻消融術治療肝癌的60例患者,探究分析CT引導下射頻消融術對所有患者的臨床療效及預後情況。結果:所有患者在手術中的血壓、脈搏及血氧飽和度與術前相比均無明顯變化(P>0.05),而治療後平均AFP和CEA檢測值均明顯低于治療前,差異均有統計學意義(P<0.05)。60例患者腫瘤完全壞死56例,佔93.3%;不完全壞死3例,佔5.0%;部分壞死1例,佔1.7%。60例患者在1年內複髮16例,佔26.7%;1年內死亡患者1例,存活59例,1年生存率為98.3%。結論:CT引導下射頻消融術(RFA)治療肝癌的臨床效果良好,值得在臨床上推廣。
목적:탐구병평개CT인도하사빈소융술(RFA)치료간암적림상효과。방법:선취2012년4월-2013년4월재본원행CT인도하사빈소융술치료간암적60례환자,탐구분석CT인도하사빈소융술대소유환자적림상료효급예후정황。결과:소유환자재수술중적혈압、맥박급혈양포화도여술전상비균무명현변화(P>0.05),이치료후평균AFP화CEA검측치균명현저우치료전,차이균유통계학의의(P<0.05)。60례환자종류완전배사56례,점93.3%;불완전배사3례,점5.0%;부분배사1례,점1.7%。60례환자재1년내복발16례,점26.7%;1년내사망환자1례,존활59례,1년생존솔위98.3%。결론:CT인도하사빈소융술(RFA)치료간암적림상효과량호,치득재림상상추엄。
Objective:To explore and evaluate the clinical effect of CT-guided radiofrequency ablation(RFA) in treatment of liver cancer.Method:60 patients who were treated by CT-guided radiofrequency ablation(RFA)in our hospital from April 2012 to April 2013 were selected,and the clinical efficacy and prognosis of CT-guided radiofrequency ablation(RFA)in treatment of 60 liver cancer patients were explored and analyzed.Result:There had no significant differences in blood pressure,pulse and blood oxygen saturation between preoperative and intraoperative (P>0.05).After treatment,the average value of AFP and CEA were significantly lower than before treatment,the differences were statistically significant(P<0.05).In all 60 patients,the number of complete tumor necrosis patients was 56(accounting for 93.3%),the number of incomplete tumor necrosis patients was 3(accounting for 5.0%),the number of partial tumor necrosis patients was 1(accounting for 1.7%).The number of patients relapsed within 1 year was 16 (accounting for 26.7%),one patient died within 1 year,1-year survival rate was 98.3%.Conclusion:The clinical effect of CT-guided radiofrequency ablation(RFA)in treatment of liver cancer is good,is worthy of clinical promotion..